Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Gallagher

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer ContraindicationsJustine V Cohen, Adam Adika, Matthew Zibelman, et al.
Trends in Immunology|March 12, 2019
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to ImmunotherapyAbdullah Al Emran, Aniruddha Chatterjee, Euan J Rodger, et al.
Pigment Cell & Melanoma Research|April 12, 2016
EZH2 as a mediator of treatment resistance in melanomaJessamy C Tiffen, Stuart J Gallagher, Hsin-Yi Tseng, et al.
Carcinogenesis|October 23, 2012
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistanceDavid Wroblewski, Branka Mijatov, Nethia Mohana-Kumaran, et al.
Pigment Cell & Melanoma Research|November 17, 2011
General strategy to analyse coat colour phenotypes in miceIrina Berlin, Flavie Luciani, Stuart J Gallagher, et al.
Pigment Cell & Melanoma Research|June 29, 2019
C57BL/6 congenic mouse NRAS<sup>Q61K</sup> melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivoValérie Petit, Jeremy Raymond, Christophe Alberti, et al.
Cancers|August 1, 2020
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two CohortsAbdullah Al Emran, Jérémie Nsengimana, Gaya Punnia-Moorthy, et al.
Cell Cycle (Georgetown, Tex.)|January 29, 2010
Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondriaMal Irvine, Suzanah Philipsz, Monika Frausto, et al.
Pathology|June 6, 2021
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysisStuart J Gallagher, Teresa Bailey, Robert V Rawson, et al.
The Journal of Investigative Dermatology|March 30, 2021
A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human MelanomaAbdullah Al Emran, Hsin-Yi Tseng, Dilini Gunatilake, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer ContraindicationsJustine V Cohen, Adam Adika, Matthew Zibelman, et al.
Trends in Immunology|March 12, 2019
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to ImmunotherapyAbdullah Al Emran, Aniruddha Chatterjee, Euan J Rodger, et al.
Pigment Cell & Melanoma Research|April 12, 2016
EZH2 as a mediator of treatment resistance in melanomaJessamy C Tiffen, Stuart J Gallagher, Hsin-Yi Tseng, et al.
Carcinogenesis|October 23, 2012
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistanceDavid Wroblewski, Branka Mijatov, Nethia Mohana-Kumaran, et al.
Pigment Cell & Melanoma Research|November 17, 2011
General strategy to analyse coat colour phenotypes in miceIrina Berlin, Flavie Luciani, Stuart J Gallagher, et al.
Pigment Cell & Melanoma Research|June 29, 2019
C57BL/6 congenic mouse NRAS<sup>Q61K</sup> melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivoValérie Petit, Jeremy Raymond, Christophe Alberti, et al.
Cancers|August 1, 2020
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two CohortsAbdullah Al Emran, Jérémie Nsengimana, Gaya Punnia-Moorthy, et al.
Cell Cycle (Georgetown, Tex.)|January 29, 2010
Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondriaMal Irvine, Suzanah Philipsz, Monika Frausto, et al.
Pathology|June 6, 2021
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysisStuart J Gallagher, Teresa Bailey, Robert V Rawson, et al.
The Journal of Investigative Dermatology|March 30, 2021
A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human MelanomaAbdullah Al Emran, Hsin-Yi Tseng, Dilini Gunatilake, et al.
Pageof 4